Centerpoint Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-94
Closed -$4K 465
2025
Q3
$4K Buy
+94
New +$4.54K ﹤0.01% 380
2023
Q4
Sell
-25
Closed -$1K 582
2023
Q3
$1K Hold
25
﹤0.01% 541
2023
Q2
$1K Hold
25
﹤0.01% 537
2023
Q1
$1K Buy
+25
New +$1.22K ﹤0.01% 532
2022
Q3
Sell
-10
Closed -$1K 414
2022
Q2
$1K Hold
10
﹤0.01% 371
2022
Q1
$1K Hold
10
﹤0.01% 382
2021
Q4
$1K Buy
+10
New +$495 ﹤0.01% 408
2018
Q3
Sell
-332
Closed -$13K 340
2018
Q2
$13K Buy
+332
New +$13.1K 0.01% 163

Other funds holding SNY

Centerpoint Advisors's SNY Position: Q4 2025 in Review

Centerpoint Advisors sold out of Sanofi (SNY) in Q4 2025, closing a stake of 94 shares — an estimated $4K sold.

Centerpoint Advisors first reported a position in SNY in Q2 2018 and held it in 8 quarters. The position peaked at $13K in Q2 2018. 757 funds tracked by Wall St. Rank hold SNY as of Q4 2025.

  • Centerpoint Advisors reported no remaining Sanofi position as of Q4 2025 after selling out during the quarter.
  • Centerpoint Advisors sold 94 Sanofi shares in Q4 2025, an estimated $4K.
  • Centerpoint Advisors first reported a position in Sanofi in Q2 2018 and held it in 8 quarters.
  • Centerpoint Advisors's Sanofi position peaked at $13K in Q2 2018.
  • 757 funds tracked by Wall St. Rank held Sanofi as of Q4 2025.

Based on Centerpoint Advisors's 13F filing for Q4 2025, filed 13 Feb 2026.